• Product & Service
  • Scientific Research Innovation
  • Our Company
  • Investor Relations
  • News
  • Human Resource
  • Mail system
CONTACT CH
Product

Chinese medicine
Immunosuppressive agents
Endocrine drugs
Digestive system drugs
Antineoplastic drugs
Cardiovascular drugs
Antibiotic drugs

Product

Medical beauty field
Medical equipment

Service Center

Security Check

Quality Hotline: 800-8571016 / 400-9057136

Scientific and technological achievements
Quality and Safety
Innovation Dynamics
  • Chinese medicine
  • Chairman Introduction
  • Joint-stock Members
  • Responsibility Interest
  • API
  • Brand Culture
  • Honor
  • Member
  • Company Overview
  • Capital structure
  • Major shareholder
  • Company announcement
  • Real-time quotes
  • Investment Advisory
  • company news
  • Industry News
  • Training Development
  • Motivating security
  • Recruitment
  • Company News
  • Industry News
  • Project Announcement
UPDATE RE POSSIBLE OFFER FOR SINCLAIR PHARMA PLC(2018-09-11)more
Director Irrevocable Undertaking(Alan Olby)(2018-08-28)more
Director Irrevocable Undertaking(Chris Spooner)(2018-08-28)more
Director Irrevocable Undertaking(Grahame Cook)(2018-08-28)more
Shareholder Letter of Intent(Toscafund)(2018-08-28)more
Shareholder Irrevocable Undertakings( Abingworth)(2018-08-28)more
Shareholder Irrevocable Undertakings(Lansdowne)(2018-08-28)more
Director Irrevocable Undertaking(Jeffery Thompson)(2018-08-28)more
Possible Recommended Cash Offer(2018-08-28)more
Extension of PUSU deadline(2018-08-23)more
Extension of PUSU deadline(2018-08-16)more
Extension of PUSU deadline(2018-08-02)more
Home Previous 1234 Next Back

A total of 4 page 37 data

  • Our Company
  • News
  • Product
  • Company Culture
  • Recruitment

  • Scientific Research Innovation
  • Service
  • Investor Relations
  • Branch Company
     

Huadong Medicine Co.,Ltd All Rights Reserved @2018 浙ICP备05051429号-1

PAGE TOP